Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2
ACS Infectious Diseases · 2024
DOI: 10.1021/acsinfecdis.4c00544 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Joshua W C Maxwell und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Faculty of Science, The University of Sydney, Sydney, New South Wales 2006, Australia. Hauptthemen laut MEDLINE: SARS-CoV-2, Administration, Intranasal, COVID-19 Vaccines, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: University of Sydney, Australian Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Faculty of Science, The University of Sydney, Sydney, New South Wales 2006, Australia.
- Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, New South Wales 2006, Australia.
- School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales 2006, Australia.
- Sydney Institute for Infectious Diseases and the Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales 2006, Australia.
- Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, New South Wales 2006, Australia.
- Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia.
ORCID-Profile: Skye Stockdale, Erica L Stewart, Caroline L Ashley, Anneliese S Ashhurst, Richard J Payne
Förderung
- University of Sydney
- Australian Research Council
Zitieren
APA
Maxwell, J. W. C., Stockdale, S., Stewart, E. L., Ashley, C. L., Smith, L. J., Steain, M., Triccas, J. A., Byrne, S. N., Britton, W. J., Ashhurst, A. S., & Payne, R. J. (2024). Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00544
Vancouver
Maxwell JWC, Stockdale S, Stewart EL, Ashley CL, Smith LJ, Steain M, et al. Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00544
BibTeX
@article{Maxwell2024,
author = {Maxwell, Joshua W C and Stockdale, Skye and Stewart, Erica L and Ashley, Caroline L and Smith, Lachlan J and Steain, Megan and Triccas, James A and Byrne, Scott N and Britton, Warwick J and Ashhurst, Anneliese S and Payne, Richard J},
title = {Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2},
journal = {ACS Infectious Diseases},
year = {2024},
doi = {10.1021/acsinfecdis.4c00544}
}
EUVIMED